Tsai et al., 2010 - Google Patents
Immunomodulating activity of Lactobacillus paracasei subsp. paracasei NTU 101 in enterohemorrhagic Escherichia coli O157H7-infected miceTsai et al., 2010
- Document ID
- 7533196514583480384
- Author
- Tsai Y
- Cheng P
- Pan T
- Publication year
- Publication venue
- Journal of agricultural and food chemistry
External Links
Snippet
The present study investigated the immunomodulating activity of Lactobacillus paracasei subsp. paracasei NTU 101 in enterohemorrhagic Escherichia coli O157: H7-infected BALB/c mice. Mice were given L. paracasei subsp. paracasei NTU 101 (108 colony-forming units) …
- 241000218587 Lactobacillus paracasei subsp. paracasei 0 title abstract description 78
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Micro-organisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
- A61K39/0291—Yersinia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tsai et al. | Immunomodulating activity of Lactobacillus paracasei subsp. paracasei NTU 101 in enterohemorrhagic Escherichia coli O157H7-infected mice | |
| Gut et al. | Salmonella infection–prevention and treatment by antibiotics and probiotic yeasts: a review | |
| Abbasi et al. | The biological activities of postbiotics in gastrointestinal disorders | |
| Engevik et al. | Biochemical features of beneficial microbes: foundations for therapeutic microbiology | |
| Drissi et al. | Metabolic role of lactobacilli in weight modification in humans and animals | |
| Tsai et al. | The immunomodulatory effects of lactic acid bacteria for improving immune functions and benefits | |
| Oelschlaeger | Mechanisms of probiotic actions–a review | |
| Ohland et al. | Probiotic bacteria and intestinal epithelial barrier function | |
| Doron et al. | Probiotics: their role in the treatment and prevention of disease | |
| Thomas et al. | Probiotics-host communication: modulation of signaling pathways in the intestine | |
| Servin | Antagonistic activities of lactobacilli and bifidobacteria against microbial pathogens | |
| Ng et al. | Mechanisms of action of probiotics: recent advances | |
| Behnsen et al. | Probiotics: properties, examples, and specific applications | |
| Rupa et al. | Recent advances in the role of probiotics in human inflammation and gut health | |
| Sanz et al. | Probiotics as drugs against human gastrointestinal infections | |
| Amalaradjou et al. | Bioengineered probiotics, a strategic approach to control enteric infections | |
| Castillo et al. | Probiotics: an alternative strategy for combating salmonellosis: immune mechanisms involved | |
| JP2004502633A (en) | Use of Lactobacillus salivarius | |
| Corcionivoschi et al. | Probiotics-identification and ways of action | |
| CA2842379C (en) | Production and use of bacterial histamine | |
| Elshaghabee et al. | Mitigation of antibiotic resistance using probiotics, prebiotics and synbiotics. A review | |
| Gionchetti et al. | VSL# 3: an analysis of basic and clinical contributions in probiotic therapeutics | |
| Das et al. | Probiotics as efficacious therapeutic option for treating gut-related diseases: Molecular and immunobiological perspectives | |
| Gu et al. | Bacteriocins: Curial guardians of gastrointestinal tract | |
| Guli et al. | Mechanism of Lactobacillus reuteri probiotic in increasing intestinal mucosal immune system |